Mabpharm (02181) Announces January 2026 Monthly Return
Bulletin Express
Feb 03
According to the latest monthly return, Mabpharm Limited (02181) reported no changes in its authorised share capital, remaining at US$5,000,000. As of January 31, 2026, the company’s total issued share count was 4,124,080,000 ordinary shares, with no treasury shares reported. The company affirmed that it meets the public float requirement of 25%.
In its share option scheme, 72,670,876 options remained outstanding and no new shares were issued pursuant to option exercises. The scheme received general meeting approval on August 10, 2018 and had no changes during the reporting month.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.